Center for Scientific Review; Notice of Closed Meetings, 13242-13243 [E8-4649]
Download as PDF
13242
Federal Register / Vol. 73, No. 49 / Wednesday, March 12, 2008 / Notices
Please note that on January 15, 2008,
the FDA Web site transitioned to the
Federal Dockets Management System
(FDMS). FDMS is a Government-wide,
electronic docket management system.
Electronic submissions will be accepted
by FDA through FDMS only.
Dated: March 6, 2008.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. E8–4903 Filed 3–11–08; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
pwalker on PROD1PC71 with NOTICES
Proposed Collection: Comment
Request; Revision of OMB No. 0925–
0002, exp. 10/31/08, ‘‘Ruth L.
Kirschstein NRSA Individual
Fellowship Application and Related
Forms’’
Summary: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
Office of Extramural Research, the
National Institutes of Health (NIH) will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Proposed Collection: Title: Ruth L.
Kirschstein NRSA Individual
Fellowship Application and Related
Forms. Type of Information Collection
Request: Revision of a currently
approved collection, OMB 0925–0002,
Expiration Date 10/31/08. Form
Numbers: PHS 416–1, 416–9, 416–5,
416–7, 6031, 6031–1. Need and Use of
Information Collection: The PHS 416–1
and 416–9 are used by individuals to
apply for direct research training
support. Awards are made to individual
applicants for specified training
proposals in biomedical and behavioral
research, selected as a result of a
national competition. The other related
forms (PHS 416–5, 416–7, 6031, 6031–
1) are used by these individuals to
activate, terminate, and provide for
payback of a National Research Service
Award. Frequency of response:
Applicants may submit applications for
published receipt dates. If awarded,
annual progress is reported and trainees
may be appointed or reappointed.
Affected Public: Individuals or
households; businesses or other forprofit; not-for-profit institutions; Federal
Government; and State, Local or Tribal
Governments. Type of Respondents:
Adult scientific trainees and
VerDate Aug<31>2005
19:30 Mar 11, 2008
Jkt 214001
professionals. The annual reporting
burden is as follows: Estimated Number
of Respondents: 34,454; Estimated
Number of Responses per Respondent:
1; Average Burden Hours Per Response:
4.1; and Estimated Total Annual Burden
Hours Requested: 142,301. The
annualized cost to respondents is
estimated at: $4,980,535. There are no
Capital Costs to report. There are no
Operating or Maintenance Costs to
report.
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
For Further Information Contact: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Ms. Mikia Currie,
Division of Grants Policy, Office of
Policy for Extramural Research
Administration, NIH, Rockledge 1
Building, Room 3505, 6705 Rockledge
Drive, Bethesda, MD 20892–7974, or
call non-toll-free number 301–435–
0941, or e-mail your request, including
your address to: curriem@od.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: March 3, 2008.
George Gardner,
Assistant Grants Policy Officer, OPERA, OER,
National Institutes of Health.
[FR Doc. E8–4871 Filed 3–11–08; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, AIDS SBIR
Biological Sciences.
Date: March 19–21, 2008.
Time: 6 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Kenneth A. Roebuck, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106,
MSC 7852, Bethesda, MD 20892, (301) 435–
1166, roebuckk@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Molecular
Mechanisms of Neuronal Development and
Regeneration.
Date: March 21, 2008.
Time: 4 p.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Lawrence Baizer, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152,
MSC 7850, Bethesda, MD 20892, (301) 435–
1257, baizerl@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel.
Member Conflicts: Cell Biology.
Date: April 8–9, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\12MRN1.SGM
12MRN1
Federal Register / Vol. 73, No. 49 / Wednesday, March 12, 2008 / Notices
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Virtual Meeting)
Contact Person: Noni Byrnes, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130,
MSC 7840, Bethesda, MD 20892, (301) 435–
1023, byrnesn@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
Dated: March 4, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–4649 Filed 3–11–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Clinical Center; Notice of Meeting
pwalker on PROD1PC71 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the NIH
Advisory Board for Clinical Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended to
discuss personnel matters, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: NIH Advisory Board
for Clinical Research.
Date: March 31, 2008.
Open: 10 a.m. to 12:45 p.m.
Agenda: To review budget and policy
issues at the NIH Clinical Center.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Room 4–2551,
Bethesda, MD 20892.
Closed: 12:45 p.m. to 2 p.m.
Agenda: To review and evaluate personnel
matters.
Place: National Institutes of Health,
Building 10, 10 Center Drive, Room 4–2551,
Bethesda, MD 20892.
Contact Person: Maureen E. Gormley,
Executive Secretary, Mark O. Hatfield
Clinical Research Center, National Institutes
of Health, Building 10, Room 6–2551,
Bethesda, MD 20892, 301/496–2897.
VerDate Aug<31>2005
19:30 Mar 11, 2008
Jkt 214001
13243
Dated: March 4, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–4654 Filed 3–11–08; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
Fiscal Year (FY) 2008 Funding
Opportunity
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel R13 Conference
Applications.
Date: April 2, 2008.
Time: 8 a.m. to 11 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B,
Rockledge Drive, 3147, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Michelle M. Timmerman,
PhD, Scientific Review Officer, Scientific
Review Program, National Institutes of
Health/NIAID, Room 3258, 6700B Rockledge
Drive, MSC–7616, Bethesda, MD 20892–
7616, 301–451–4573,
timmermanm@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: March 4, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E8–4652 Filed 3–11–08; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Substance Abuse and Mental Health
Services Administration
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award a
Single Source Grant to the National
Association of State Alcohol and Drug
Abuse Directors (NASADAD).
SUMMARY: This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) intends to award
approximately $600,000 (total costs) per
year for up to three years to the National
Association of State Alcohol and Drug
Abuse Directors (NASADAD). This is
not a formal request for applications.
Assistance will be provided only to the
National Association of State Alcohol
and Drug Abuse Directors (NASADAD)
based on the receipt of a satisfactory
application that is approved by an
independent review group.
Funding Opportunity Title: TI–08–
002.
Catalog of Federal Domestic
Assistance (CFDA) Number: 93.243.
Authority: Section 1935 of the Public
Health Service Act, as amended.
Justification: Only the National
Association of State Alcohol and Drug
Abuse Directors (NASADAD) is eligible
to apply. The Substance Abuse and
Mental Health Services Administration
(SAMHSA) is seeking to award a single
source grant to the National Association
of State Alcohol and Drug Abuse
Directors (NASADAD) to facilitate
collaborative activities between
SAMHSA and the States to assist
SAMHSA in its development and
implementation of the National
Outcome Measures (NOMs).
NASADAD’s membership is
composed of the State substance abuse
authorities (SSAs). SSAs are the
recipients of SAMHSA’s Substance
Abuse Prevention and Treatment
(SAPT) Block Grant funds. Grant
activities will focus on areas of mutual
interest and will help support the
States’ ability to respond to changes
brought about by the transition of
management of the SAPT Block Grant to
a performance and outcomes focus
based upon the NOMs and other
information. These collaborative
activities will assist SAMHSA in its
development, implementation and
management of the SAPT Block Grant
Program, and will assist States in the
E:\FR\FM\12MRN1.SGM
12MRN1
Agencies
[Federal Register Volume 73, Number 49 (Wednesday, March 12, 2008)]
[Notices]
[Pages 13242-13243]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-4649]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, AIDS SBIR Biological Sciences.
Date: March 19-21, 2008.
Time: 6 a.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Kenneth A. Roebuck, PhD, Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5106, MSC 7852, Bethesda, MD
20892, (301) 435-1166, roebuckk@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Molecular Mechanisms of Neuronal Development and
Regeneration.
Date: March 21, 2008.
Time: 4 p.m. to 7 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call)
Contact Person: Lawrence Baizer, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4152, MSC 7850, Bethesda, MD
20892, (301) 435-1257, baizerl@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel.
Member Conflicts: Cell Biology.
Date: April 8-9, 2008.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
[[Page 13243]]
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Virtual Meeting)
Contact Person: Noni Byrnes, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD
20892, (301) 435-1023, byrnesn@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS).
Dated: March 4, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-4649 Filed 3-11-08; 8:45 am]
BILLING CODE 4140-01-M